NEXSTAR PHARMACEUTICALS
NEXSTAR PHARMACEUTICALS
Industry:
Health Care Pharmaceutical
Founded:
1991-01-01
Address:
Boulder, Colorado, United States
Country:
United States
Status:
Active
Contact:
(303)444-5893
Similar Organizations
AskGene Pharma
AskGene Pharma is a pharmaceuticals company.
Cary Pharmaceuticals
Cary Pharmaceuticals is a pharmaceutical development company.
Novation Pharmaceuticals
Novation Pharmaceuticals is a therapeutics company .
More informations about "NeXstar Pharmaceuticals"
Gilead Acquisition Of NeXstar Completed - Gilead Sciences
Jul 29, 1999 · Gilead Sciences, Inc. (Nasdaq: GILD) and NeXstar Pharmaceuticals, Inc. (Nasdaq: NXTR) today announced that the stockholders of Gilead and NeXstar approved the merger …See details»
NeXstar Pharmaceuticals - Crunchbase Company Profile & Funding
NeXstar Pharmaceuticals is a Pharmaceutical company. NeXstar Pharmaceuticals was acquired by Gilead Sciences on Jul 29, 1999. Where is NeXstar Pharmaceuticals's headquarters? …See details»
Gilead Sciences and NeXstar Pharmaceuticals to Merge
Mar 1, 1999 · Gilead Sciences, Inc. (Nasdaq: GILD) and NeXstar Pharmaceuticals Inc. (Nasdaq: NXTR) today announced a definitive agreement whereby Gilead will acquire NeXstar in an all …See details»
NeXstar Pharmaceuticals, Inc. - Drug pipelines, Patents, Clinical ...
Explore NeXstar Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 3 clinical trials, 3 news, and 105 literature, Drug:Oligonucleotide (L …See details»
NeXstar Pharmaceuticals - PitchBook
Information on acquisition, funding, cap tables, investors, and executives for NeXstar Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
NeXstar Pharmaceuticals Inc - Company Profile and News
NeXstar Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers, develops, and manufactures products to treat life-threatening illnesses, including cancer,...See details»
NeXstar Pharmaceuticals - Products, Competitors, Financials, …
NeXstar Pharmaceuticals was a Healthcare/Biotechnology company based in Boulder, Colorado. NeXstar Pharmaceuticals was acquired in 1999. You're one click away from the most …See details»
Gilead acquires NeXstar - Nature Biotechnology
Apr 1, 1999 · Gilead gains NeXstar's antifungal, Ambisome, and the cancer therapy DaunoXome (both on the market) and three candidates in development, including the antibacterial, MiKasome.See details»
Gilead Sciences acquires NeXstar Pharmaceuticals - 1999-07-29 ...
Jul 29, 1999 · Acquiring Organization: Gilead Sciences Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical …See details»
Gilead Sciences will Acquire Nexstar Pharmaceuticals
Mar 2, 1999 · Gilead Sciences Inc. and NeXstar Pharmaceuticals Inc. recently announced a definitive agreement whereby Gilead will acquire NeXstar in an all-stock, tax-free pooling-of …See details»
Gilead Sciences and NeXstar Pharmaceuticals to Merge - CMOCRO
Gilead Sciences, Inc. (Nasdaq:GILD) and NeXstar Pharmaceuticals Inc. (Nasdaq:NXTR) today announced a definitive agreement whereby Gilead will acquire NeXstar in an all-stock, tax-free …See details»
Gilead Sciences to merge with NeXstar - Pharmaceutical industry …
Mar 2, 1999 · Gilead Sciences has signed a definitive agreement to acquire NeXstarPharmaceuticals in an all-stock action.See details»
NeXstar Pharmaceuticals - Tech Stack, Apps, Patents & Trademarks
This year, NeXstar Pharmaceuticals is projected to spend $544.2M on IT, according to Aberdeen.See details»
Gilead Sciences acquires NeXstar Pharmaceuticals
Gilead Sciences, Foster City, Calif., will buy NeXstar Pharmaceuticals, Boulder, Colo., for $550 million in a stock-for-stock transaction, creating a biopharmaceutical firm valued at $2 billion.See details»
In Brief: NeXstar Pharmaceuticals - Medtech Insight
Feb 27, 1995 · NeXstar Pharmaceuticals: The merger between NeXagen and Vestar has been completed to form NeXstar, a company with $45 mil. in sales and $50 mil. in total revenues. …See details»
Companies Merge to Form NeXstar - Cancer Network
May 1, 1995 · BOULDER, Colo--NeXagen, Inc. and Vestar, Inc. have merged to form NeXstar Pharmaceuticals, Inc. One focus of the new company will be the liposomal delivery of …See details»
NeXstar seeks better valuation through disintegration
NeXstar was created in 1995 by the merg er of Vestar and Nexagen. Patrick Mahaffy (who became president of NeXstar) merged Nexagen's combinatorial chemistry technol ogy with …See details»
NX-213 - Drug Targets, Indications, Patents - Synapse
NX-213: a VEGFR antagonists Drug, Initially developed by NeXstar Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Mechanism: VEGFR antagonists (Vascular …See details»
Oligonucleotide (L-selectin)(NeXstar) - Drug Targets, Indications ...
Oligonucleotide (L-selectin) (NeXstar): a L-sel inhibitors Drug, Initially developed by NeXstar Pharmaceuticals, Inc., Now, its global highest R&D status is Pending, Mechanism: L-sel …See details»
FDA approves DaunoXome as first-line therapy for Kaposi's
AIDS: The Food and Drug Administration (FDA) approved NeXstar Pharmaceuticals' anticancer drug DaunoXome (daunorubicin citrate liposome injection) as a first-line cytotoxic therapy for …See details»